Microbia

Bioengineering production strains - Microbia develops new methods

The recently published issue of Nature Biotechnology outlines a new method developed by Microbia Ltd.'s scientists for rapidly identifying genes required for the production of industrial molecules produced in microbes. This is an advancement in the company's ability to improve the properties// of m...

Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide

...ronic constipation (CC). Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Microbia, Inc. (formerly microbia Precision Engineering), a majority-owned subsidiary of Ironwood, is an industrial biotechnology company developing and commercializing novel bioproces...

Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment

...r the fiscal year totaled $3.06 per share as compared to reported earnings per share of $1.41 in fiscal 2007. Excluding the licensing payments made to microbia and Novexel, adjusted net income for the fiscal year ended March 31, 2008 would be $1,123,552,000, or $3.55 per fully diluted share. During fiscal yea...

Microbia in Medical Technology

Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

...ronic constipation (CC). Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Microbia, Inc. (formerly microbia Precision Engineering), a majority-owned subsidiary of Ironwood, is an industrial biotechnology company developing and commercializing novel bioproces...

Ironwood Announces Linaclotide European Licensing Agreement with Almirall

...ronic constipation (CC). Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Microbia, Inc. (formerly microbia Precision Engineering), a majority-owned subsidiary of Ironwood, is an industrial biotechnology company developing and commercializing novel bioproces...

Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain

...bitors for the treatment of hypercholesterolemia. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. microbia Precision Engineering, Inc., a majority-owned subsidiary of Ironwood, is an industrial biotechnology company developing and commercializing novel biop...

Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3

...bitors for the treatment of hypercholesterolemia. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. microbia Precision Engineering, Inc., a majority-owned subsidiary of Ironwood, is an industrial biotechnology company developing and commercializing novel biop...

Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results

...bitors for the treatment of hypercholesterolemia. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. microbia Precision Engineering, Inc., a majority-owned subsidiary of Ironwood, Inc., is an industrial biotechnology company developing and commercializing nove...

Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies

.... Once the full analysis of the data is completed, microbia and Forest Laboratories plan to present the result...de provides protection to 2025. In September 2007, microbia and Forest entered into a 50/50 collaboration to c...e linaclotide in United States. About Microbia microbia (http://www.microbia.com ) is an entrepreneurial ...

Microbia Announces Positive Phase 2 Results for Its Investigational Compound Linaclotide

... - CAMBRIDGE, Mass., May 21, 2007 /PRNewswire/ -- microbia today announced the presentation of data from a Ph...w.ddw.org/">www.ddw.org . About Microbia, Inc. microbia (microbia as momentum builds for the company," said Mr. Walt... unique approach to metabolic pathway engineering, microbia has made impressive progress over the past several...

Microbia PE Bolsters Senior Management Team; Positions Company for Commercializing Proprietary Bioproducts

... LEXINGTON, Mass., Dec. 17 /PRNewswire/ -- microbia Precision Engineering, Inc. (Microbia) announced t...terials. Currently at the commercialization stage, microbia believes its natural fermentation-based processes ...t new senior management positions is a key step as microbia moves rapidly toward market introduction of its fi...

Microbia Announces Name Change to Ironwood Pharmaceuticals

...s. In addition, the name Ironwood encompasses the inorganic and organic -- the properties of essential elements and the characteristics of life. "As microbia has developed and progressed, we have outgrown the usefulness of the name Microbia," said Peter Hecht, CEO. "With that in mind, we sought a name for t...

Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration

...tially pay Microbia $70 million in licensing fees. microbia and Forest will jointly and equally fund developme...exclusive rights in Canada and Mexico and will pay microbia a royalty on sales in these countries. microbia retains all rights to the product outside of North...